Previous Article | Next Article 
Journal of Clinical Microbiology, February 2001, p. 539-543, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.539-543.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immunodiagnostic Identification of Dairy Cows Infected with
Prototheca zopfii at Various Clinical Stages and
Discrimination between Infected and Uninfected Cows
Uwe
Roesler,*
Holger
Scholz, and
Andreas
Hensel
Institute of Animal Hygiene and Veterinary
Public Health, Faculty of Veterinary Medicine, University of
Leipzig, D-04103 Leipzig, Germany
Received 3 July 2000/Returned for modification 26 September
2000/Accepted 17 November 2000
 |
ABSTRACT |
Protothecosis is a severe form of mastitis in cattle that is caused
by colorless algae of the genus Prototheca. So far, no suitable serological test for the identification of infected animals is
available for routine diagnosis. In this study an indirect enzyme-linked immunosorbent assay (ELISA) for the identification of
infected cows and for discriminating among infected cows at various
clinical stages was developed. Immunoglobulin G (IgG) in serum and IgA
and IgG1 in whey were used as antibody isotypes. The ELISA was
evaluated using serum and whey from animals at different clinical
stages of infection. A total of 12 cows with acute clinical manifestation of protothecal mastitis, 22 cows with clinical signs of
chronic mastitis, 40 Prototheca zopfii-negative cows, and
18 cows with chronic clinical signs and earlier cultures positive for
P. zopfii but with presently negative culturing results
were investigated. A sensitivity of 96% and a specificity of 94% were calculated for the ELISA based on IgA levels. Intra-assay and interassay variations were calculated to be 6.08 and 6.32%,
respectively. Based on these data, this ELISA was found to be suitable
for discrimination between infected and uninfected animals and might
therefore be useful for screening affected herds.
 |
INTRODUCTION |
Members of the species of the genus
Prototheca are unicellular colorless algae. They are
saprophytes which can be isolated from a variety of environmental
sources, including plants, soil, drinking and marine water, sludge, the
feces of domestic animals (e.g., cattle, dogs, salmon, and pigs) or
wild animals (e.g., deer, rats, mice, or rabbits), and barn floors
(2, 10, 23, 30).
Both, Prototheca zopfii and P. wickerhamii have
been reported as the etiologic agents of protothecoses in humans and
animals. The rare cases of human protothecoses are caused predominantly by P. wickerhamii and occur as local and systemic
infections, mainly in immune suppressed patients, e.g., patients
infected with human immunodeficiency virus, or treated with
cortisone (7, 20, 32, 34; A. Kunova, T. Kollar, S. Spanik, and V. Kremery, Jr., Letter, J. Chemother.
8:166-167, 1996).
P. zopfii can cause severe local and systemic infections in
domestic animals, especially in dogs and cows. The first case of
bovine mammary infection was reported in 1952 (17).
Whereas in the past only sporadic cases of Prototheca
mastitis have been observed, cases of acute to chronic mastitis are
recognized increasingly today to be endemic worldwide (1, 9, 13,
18, 24).
Due to the ubiquitous occurrence of P. zopfii, fecal samples
of dairy cows in herds without a history of protothecal mastitis can be
found to be culturally positive at rates of 20 to 70% (2, 11). Prototheca mastitis can be transmitted from cow
to cow during milking (9, 28, 31). The incidence of
infections depends on predisposing factors such as poor environmental
conditions or insufficient milking hygiene (3, 9, 30). The
existence of a particular mastitis-associated variant of P. zopfii (variant II) has been discussed elsewhere (4, 5,
29).
Since P. zopfii is highly resistant to all known
chemotherapeutics, infected cows should be removed from the herd
(3, 8). Additionally, chronically infected cows can become
intermittent shedders (27). A reliable identification of
those individuals would reduce the risk of infection of uninfected cows
or contamination of the farm environment.
The diagnosis of Prototheca mastitis is still based upon the
time-consuming cultivation on Sabouraud-dextrose-agar medium and on the
additional investigation of lactophenol cotton blue-stained cells by
light microscopy (3, 9, 24). However, due to the slow
growth of most Prototheca strains and the intermittent excretion of the organisms, these methods cannot be used for stringent control measures (27).
In the few available previous immunological studies, detection of
anti-Prototheca immunoglobulin G (IgG) in serum using
counterimmunoelectrophoresis tests and an enzyme-linked immunosorbent
assay (ELISA) showed poor sensitivity and specificity. Additionally,
their use for routine diagnosis (5, 15) was limited.
Although, the presence of specific IgA antibodies in whey from
lactating cows could be demonstrated by immunodiffusion, this test
system was unsuitable for herd screening because it is too
labor-intensive (12).
Therefore, the aim of this study was to develop a highly specific and
sensitive ELISA suitable for diagnostics at the herd level. Our results
demonstrate the potential of the ELISA to discriminate cows showing
different clinical stages of infection from uninfected animals.
 |
MATERIALS AND METHODS |
Alga strains.
P. zopfii type strain SAG 263-4 and
reference strain SAG 2021 were obtained from the Culture Collection of
Algae at the University of Göttingen, Göttingen, Germany.
Strain SAG 263-4 was originally isolated from human intestine. P. zopfii SAG 2021 is a virulent isolate associated with an outbreak
of mastitis in a dairy herd in Saxony, Germany, and was isolated from a
case of a severe acute mammary infection in a lactating cow.
Alga cultivation and biochemical analyses.
All strains were
routinely grown on Sabouraud-dextrose-agar medium (Difco Laboratories,
Detroit, Mich.) at 37°C under aerobic conditions. For diagnostic
purposes, aliquots of 50 µl from quarter or composite milk samples
were streaked onto plates. After 72 and 120 h, plates were
examined for the growth of Prototheca. Any colonies
resembling Prototheca spp. were subcultured once. Smears
were made from colonies of interest and stained with lactophenol cotton
blue. Specimens were investigated microscopically for characteristic morphology, i.e., the presence of sporangiospores in the sporangium. In
order to distinguish P. zopfii strains from P. wickerhamii, each isolate was additionally tested for assimilation
properties in OF-Broth Medium (Difco Laboratories). The assimilation of
glucose but not of trehalose indicated the growth of P. zopfii. The assimilation of trehalose was taken as a
discriminating feature for the presence of P. wickerhamii.
To identify different variants of P. zopfii, each
isolate was tested auxanographically for the assimilation of glycerol
or galactose on Prototheca isolation medium
(22). A strong assimilation activity of galactose and
glycerol within 48 h indicated P. zopfii variant I. P. zopfii variant II did not show the assimilation of
galactose, whereas the P. zopfii variant III was not able to
utilize glycerol (4).
Preparation of genomic DNA.
Alga cultures were grown on
Sabouraud-agar plates for 48 h at 37°C. Cells were harvested by
centrifugation (ca. 5,000 × g, 10 min) and broken in a
mortar with a pestle and sterile sea sand in liquid nitrogen. Then, 30 mg of the powder was transferred to 1.5-ml Eppendorf tubes and mixed
with 500 µl of preheated CTAB buffer (2% cetyltrimethylammonium
bromide [CTAB; wt/vol]; 20 mM EDTA; 1.4 M NaCl; 1%
polyvinylpyrrolidone; 100 mM Tris, pH 8.0). The mixture was held at
65°C for 5 min. One volume (percent [vol/vol]) of
chloroform-isoamyl alcohol (24:1) was added and mixed. After centrifugation (5,000 × g, 10 min), the supernatant
was transferred to a new tube and mixed with a 1/5 volume (percent
[vol/vol]) of a 5% CTAB solution (5% CTAB, 0.7 M NaCl). DNA was
precipitated by adding 2 volumes of cold ethanol (96%) to the
supernatant and pelleted by centrifugation (15,000 × g, 30 min, 4°C). The pellet was dried under vacuum and
resuspended in 20 µl of double-deionized H2O for further use.
Species confirmation of the coating strain by rDNA-PCR
analysis.
P. zopfii strains SAG 293-4 and SAG 2021 were
compared by partial 18S ribosomal DNA (rDNA) sequencing. Total DNA of
both strains was prepared as described above. For amplification of the
18S rDNA, the primer pair wicker-18f (5'-AACCTGGTTGATCCTGCCAGT-3') and wicker-18r (5'-TGATCCTTCTGCAGGTTCACC-3') was
designed on the basis of the known sequence information of the 18S rDNA
of P. wickerhamii (GenBank accession no. X56099). PCR
amplification was carried out with 1 U of Taq DNA
polymerase, 1 µg of DNA, 1 µmol of each primer, and a 200 µM
concentration of each deoxynucleoside triphosphate in a Perkin-Elmer
2400 thermal cycler. The cycle conditions were as follows: 80 s of
denaturation at 94°C and 90 s of extension at 72°C. The
annealing conditions for amplification were chosen according to the
guanine-cytosine content of the corresponding oligonucleotides. The
amplification product was analyzed on a 1% (wt/vol) agarose gel and
purified using PCR Purification Kit (Qiagen, Inc., Chatsworth, Calif.).
The PCR fragment was sequenced directly using the internal primer
wicker-18S-fseq1 (5'-TGCCAGTAGTCATATGCTTGT-3') and further
sequence-derived oligonucleotides. Nucleotide sequence determination
was carried out with a LI-COR DNA sequencer model 4000 by the dideoxy
chain termination method (26). The sequence was analyzed
using the Wisconsin Package version 8.1 UNIX (GCG) software package.
Preparation of polyclonal antibodies.
Hyperimmune sera
directed against P. zopfii were developed in rabbits. A
total number of 107 cells/ml in phosphate-buffered saline
of either strain SAG 263-4 or strain SAG 2021 were emulsified with an
equal volume of Freund incomplete adjuvant (Sigma), and 1 ml was used
to inoculate New Zealand White rabbits with an approximate body mass of
2.5 to 3.5 kg intradermally. Starting at 3 weeks postinfection, the
rabbits were boosted intravenously biweekly three times with
107 viable cells of the homologous strain. At 7 days after
the last application (10 weeks after the original inoculations), the
rabbits were bled and sera were obtained.
Antigen preparation procedures, SDS-PAGE, and
immunoblotting.
Pools were made from whey and blood serum samples
from cows with chronic mastitis due to naturally P. zopfii
infection and from noninfected lactating cows. Specimens were analyzed
for specific IgG, IgG1, and IgA concentrations. Different antigen
preparations were tested in order to gain the most suitable antigen
preparation for coating or immunoblotting. Prototheca cells
were thus resuspended in distilled water without any further treatment,
broken by repeated freezing-thawing cycles in liquid nitrogen,
ultrasonicated, heated (100°C, 5 min), and digested with proteinase
K. Protein fractions (pellets or supernatants) of each preparation were
separated on 10% denaturing sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) gels (Protean II; Bio-Rad)
(16). Proteins were transferred to a polyvinylidene
difluoride membrane for immunoblotting. Immunodetection procedures were
carried out by standard procedures (25). To minimize
nonspecific background during immunoblotting, a synthetic blocking
reagent (Roti-Block; Carl Roth, Ltd., Karlsruhe, Germany) was used.
Detection was carried out colorimetrically using VIP-Kits (Vector
Laboratories, Inc.) or by chemiluminescence using ECL-Kits (Amersham
Pharmacia Biotech, Ltd., Buckinghamshire, United Kingdom) using
peroxidase-conjugated secondary antibodies.
Classification of P. zopfii-infected cows.
Lactating cows with a history of either acute or chronic P. zopfii infection were included in the present study. A total of 92 cows were evaluate by anamnestic, cultural, and clinical criteria. The
animals were then assigned to the following groups: group A, cows
(n = 12) with acute Prototheca mastitis
(swollen udder with hard quarters, quarters secreting watery milk with
white flakes, no fever) and positive cultural Prototheca
isolation; group B, cows (n = 22) with chronic clinical
symptoms of Prototheca mastitis (atretic quarters reduced in
size, significant decrease in milk production, no fever, duration of
clinical signs for >2 weeks) and a current positive culture; and group
C, cows (n = 18) showing chronic clinical signs of
mastitis (atretic udder, significant decrease in milk production, no
fever, duration of clinical signs for >2 weeks) combined with earlier
positive cultural findings but with negative cultural results when
investigated. The negative control group (group D) consisted of
healthy, uninfected cows (n = 40) without a history of
Prototheca mastitis. Each animal in this group was tested
negatively for P. zopfii by culture. In addition, the milk
of all cows was routinely investigated by culture on day 5 postpartum.
Sample collection and preparations.
Serum and milk samples
were collected in parallel from cows included in the present study. To
extract whey, milk samples were mixed with 0.1 mU of chymotrypsin
(Rennin; Fluka, Ltd.) per 10 ml of milk. After incubation for 30 min at
37°C, the samples were centrifuged. Serum samples obtained from blood
and whey preparations were allowed to clot overnight at 4°C before separation.
ELISA procedures.
In order to obtain antigen for whole-cell
ELISA, cultures were incubated for 36 h at 37°C on
Sabouraud-dextrose-agar medium plates. Algae were rinsed from the
plates with 2 ml of carbonate buffer (pH 9.6) and subsequently pooled.
The total cell count was adjusted to 107 cells/ml in
carbonate buffer. For coating, 100 µl of this suspension was
transferred to each well of 96-well microtiter plates (Maxisorp; lot
no. 4-42404; Nunc, Ltd., Roskilde, Denmark). All incubations and wash
steps were done as described previously (12). As a positive reference standard, a randomly selected serum pool obtained from 15 chronically infected cows was used. The negative control consisted of a pooled serum from 10 healthy lactating cows obtained from a herd without any history of Prototheca mastitis over
a period of 5 years. The following affinity-purified polyclonal monospecific peroxidase-conjugated conjugates were used: anti-bovine IgG, anti-bovine IgG1, anti-bovine IgA, or anti-bovine IgM (Bethyl Laboratories, Inc., Montgomery, Tex.). The plates were washed again
four times with phosphate-buffered saline-Tween. The enzymatic reaction was developed with an ABTS (Boehringer-Mannheim)-based chromogen and measured by a computer-controlled photometer (Multiscan MCC-340; Flow Lab, Inc., McLean, Va.) (12). Antibody
concentrations were expressed as ELISA units (EU) using the positive
reference standard method (6).
ELISA performances and statistical analyses.
Data were
calculated using a computer-based program developed for ELISA
evaluation (21). The values of positive reference standards were set to 100 EU. The cutoff EU value was calculated to be
three standard deviations above the mean of the negative controls. The
activities of isotype-specific antibodies were calculated and plotted
as notch boxes. The median (internal horizontal line), upper, and lower
quartiles (the oblique margins of the boxes), the 95% confidence
limits (the upper and lower horizontal margins of the boxes), and the
extreme values are shown (19). Significant differences
between EU data of infected cows at the three various clinical stages
(groups A, B, and C) and the uninfected control group (group D) were
tested by Student t tests for unpaired observations or by
Welch's test. A P value of
0.05 was considered to be
significant. ELISA results were evaluated by calculation of the
sensitivity and the specificity (34).
To investigate the reproducibility of all ELISA systems, intra-assay
and interassay variations were determined for IgG, IgG1, and IgA
isotypes. For intra-assay variation, each well of two plates was coated
with positive standard serum diluted 1:800 for IgG in serum and 1:400
for IgA or IgG1 in whey. For interassay variation,
specimens obtained from 10 positively and 10 negatively tested cows
were investigated at least five times each. In order to compare the
whole-cell ELISA antigens of strains SAG 263-4 and SAG 2021, suspensions of both alga strains were weighed and adjusted. Microtiter
plates were coated with both of these antigens and then tested by
checkerboard titration. The evaluation of intra-assay variation and
interassay variation was performed as described previously
(14).
Due to similarities in culture morphology, pathogenesis, and the
clinical signs of bovine mastitis, the pathogenic yeast
Cryptococcus neoformans was chosen for the testing of
cross-reactivity. A rabbit-derived
hyperimmune sera developed against
C. neoformans was tested on
microtiter plates coated with
P. zopfii SAG 2021 as the
antigen.
 |
RESULTS |
Species confirmation.
Based on genetic, morphologic, and
biochemical properties, all Prototheca strains isolated in
this study could be assigned to the species P. zopfii,
variant II.
Choice of strains, antigen preparation procedures, and
immunoblotting.
In order to select a strain for coating, P. zopfii SAG 263-4 and SAG 2021 were compared. Noticeable
differences in their immunogenic properties were obvious when Western
blotting with rabbit hyperimmune serum was performed. Two immunogenic
components at molecular masses of 90 kDa and 100 kDa were detected for
SAG 263-4 and SAG 2021. An additional common signal occurred at a
molecular mass of 45 kDa which was weak in case of SAG 263-4 (data not
shown). In their partial 18S rDNA sequence they did not differ (data
not shown).
When compared as whole-cell antigens in a checkerboard titration, SAG
2021 revealed consistently significant stronger signals
than SAG 263-4. Based on these results and on the human origin
of strain SAG 263-4, SAG
2021 was chosen as the strain coated
for all of the ELISAs. Immunoblot
analyses of the different antigen
preparations revealed that the main
immunogenic component was
already released when the cells were diluted
in distilled water.
No additional immunogenic components were set free
from the cells
by further treatment, such as heating or sonication
(data not
shown)
The presence of specific IgG antibodies in serum and IgA antibodies in
whey samples of cows with protothecal mastitis is shown
by an identical
immunogenic double band, located at 30 and 32
kDa (Fig.
1, lanes 2 and 4). No signal was obtained
with systemic
and local antibodies obtained from
Prototheca-negative cows (lanes
1 and 3).

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoblot of a preparative SDS-PAGE analysis of
whole-cell antigen of P. zopfii to detect specific IgG
antibodies in serum and IgA antibodies in whey. Serum and whey were
obtained from culture-positive (+) and culture-negative ( ) dairy
cows. Immunogenic components of 30 and 32 kDa are indicated by
arrows.
|
|
ELISAs.
The statistical evaluation of the ELISA is summarized
in Table 1. Animals with a clinical history of Prototheca
mastitis but with negative culturing results were not considered. As a positive cutoff value, the total of the three standard deviations and
the mean EU value of the culture negative animals was defined. The
highest sensitivity (96%) and the lowest cutoff value (1 EU) was
calculated for the ELISA when whey-IgA was used. Whereas the sensitivity of the serum IgG ELISA was significantly lower. No significant levels of IgM and IgA were detected in serum. A
cross-reactivity with a hyperimmune serum of a rabbit immunized with
C. neoformans was not observed.
The antibody concentrations against
P. zopfii measured with
different ELISAs are depicted in Fig.
2.
In comparison to all
other clinical stages of infection, acutely
infected cows revealed
the highest antibody quantity in serum and in
whey. A significant
discrimination between acute and chronically
infected cows (
P < 0.05) was observed when serum IgG
was measured (Fig.
2A). A
similar result was found when the sera of
chronically infected
cows with positive culture results were compared
to chronically
infected cows that had earlier positive culture results
but a
negative culture result at the time of investigation. A
significant
discrimination for IgG could also be demonstrated when the
sera
of chronically infected cows with positive culture results and
the
sera of uninfected animals (
P < 0.05) were analyzed.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
ELISA activity of IgG (dark gray boxes) in serum (A) and
of IgA (dotted boxes) (B) and IgG1 (white boxes) (C) in whey of cows
with various clinical stages of P. zopfii infection. A
significant discrimination (P < 0.05) of acutely
infected culture-positive versus chronically infected culture-positive
animals is indicated by asterisks. , Significant discrimination
(P < 0.05) of chronically infected culture-positive
versus chronically infected culture-negative animals. A significant
discrimination (P < 0.05) of chronically infected
culture-positive versus noninfected cows is indicated by a dagger
symbol. The cutoff value for positive test results is pointed by the
dotted horizontal line.
|
|
Analyzing whey antibodies reacting with
P. zopfii antigens,
chronically infected culture positive cows could be clearly
distinguished
from previously culture positive animals with an actual
negative
finding (Fig.
2B and C). A significant discrimination between
chronically infected culture positive cows and uninfected animals
(
P < 0.05) was found in whey samples. A significant
number of
chronically infected culture positive animals showed a higher
IgA antibody concentration in whey compared to cows with acute
diseased.
On the basis of the low cutoff level chosen for the whey samples, 50 and 39% of the animals with previous cultural findings
of
Prototheca, which were currently culture negative, could be
identified by investigating the IgA level and the level of IgG1
in
whey. Specific antibodies were not detectable in uninfected
animals
when milk serum was
used.
 |
DISCUSSION |
Thus far, no immunological test for the screening of dairy herds
infected with P. zopfii exists. A rapid identification of these cows would reduce the risk of having the infection spread within
the herd. In this study we developed an ELISA based on the detection of
P. zopfii-specific IgA and IgG1 antibodies in whey and IgG
antibodies in serum. This system allows the identification of infected
animals and the discrimination of cows that are infected but are at
various clinical stages. The ELISA might now be used as a control
measure at the herd level.
The results of our ELISAs clearly demonstrated that
anti-Prototheca IgA and IgG1 antibodies in whey are most
suitable for the immunological detection of
Prototheca-infected cows, which is underlined by the high
sensitivities of 96 and 94%, and also by the low cutoff of 1.0 EU. In
cows, the (natural) way of infection is believed to be the contact of
the algae with the udder epithelium. This is reflected by the presence
of IgA antibodies in the udder, the site of clinical manifestation
(12). A sensitivity not sufficient for diagnostic purposes
was obtained when (blood) serum IgG antibodies were investigated (Table
1). This finding might be explained by a
frequent enteric contact with the algae (13). However, the
ELISA for the detection of IgG in serum can be used for the identification of nonlactating cows or of animals with atretic udder
quarters. Different methods of antigen preparation and the comparison
of different strains demonstrated that the whole-cell antigen of the
mastitis strain SAG 2021 is most suitable for coating.
Since the actual infection status of the cows with previous cultural
findings of Prototheca but with presently culture negative results was uncertain, the sensitivity and specificity of the different
ELISAs were calculated without using the data for these animals. On the
one hand, these animals might represent frequently occurring
intermittent shedders of the pathogen (16, 31). On the
other hand, the cows might also have overcome the infection. The
chronic clinical signs of mastitis such as the permanent decline of
milk production and atretic udder quarters would persist in these cases
(27). By using the ELISA for the detection of
anti-Prototheca IgA antibodies in whey, 50% of these cows
were identified as infected animals. When IgG1 antibodies against
Prototheca were tested, the number of positively identified
animals dropped to a rate of only 39%. A diagnostic interpretation of
this finding is difficult, since controlled experimental infection,
including the monitoring of specific immunoglobulin isotypes in serum
and secretions was not carried out yet. One possible explanation for
why 50% of the cows tested positive by ELISA in the group with chronic
signs of infection but did not have positive cultural findings is that the test correctly identified persistently infected cows. This is
underlined by the general finding that specific IgA antibodies are
present in the sera of persistently infected animals and humans (14, 15, 19). Hence, a negative result obtained for this group could indicate convalescence. A third explanation is the occurrence of false-positives. However, this explanation is unlikely because the specificity was 94%. Negative findings may indicate falsely negative but nevertheless infected animals. In future investigations, the kinetics of antibody responses of chronically infected animals and intermittent shedders need to be clarified in
greater detail.
The advantage of our ELISA compared to plate culturing is the simple
and reliable identification of infected cows. In comparison to the
classical culture method and the subsequent microscopic investigation,
the use of our ELISA has reduced the time needed to make a diagnosis of
an infected animal to 12 h.
A question yet to be addressed in literature, is whether antibodies can
be protective or algicidal for P. zopfii organisms. Our
findings demonstrate the presence of antibodies against immunogenic components at a molecular masses of 30 and 32 kDa in serum and in whey
(Fig. 1). The role of these two structures in the pathogenesis of
protothecal bovine mastitis has to be elucidated in further experiments
in order to investigate the horizontal and vertical routes of infection.
In summary, serologic diagnostic measures for correct identification of
protothecal mastitis in dairy cows by ELISA provide a rapid, reliable,
and inexpensive screening test for infection with P. zopfii
compared to microbiological examination by plate culturing. Early
identification of subclinically infected animals will reduce the risk
of new infections and contamination of the environment. The test might
also be a promising tool for the remediation of infected dairy herds.
 |
ACKNOWLEDGMENTS |
We thank A. Meyer for collecting specimens. The technical
assistance of E. Brumme and D. Rüster is also gratefully
acknowledged. We thank F. Wagner for providing the rabbit
anti-Cryptococcus sera. Finally, we thank H. Neubauer and
L. D. Sprague for useful discussions, critically reading of the
manuscript, and for correcting the English.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Tierhygiene und Öffentliches Veterinärwesen,
Veterinärmedizinische Fakultät, Universität Leipzig,
An den Tierkliniken 43, D-04103 Leipzig, Germany. Phone:
49-341-97-38150. Fax: 49-341-97-38198. E-mail:
roesler{at}vetmed.uni-leipzig.de.
 |
REFERENCES |
| 1.
|
Aalbaek, B.,
H. E. Jensen, and A. Huda.
1998.
Identification of Prototheca from bovine mastitis in Denmark.
APMIS
106:483-488[Medline].
|
| 2.
|
Anderson, K. L., and R. L. Walker.
1988.
Sources of Prototheca spp. in a dairy herd environment.
J. Am. Vet. Med. Assoc.
193:553-556[Medline].
|
| 3.
|
Baumgärtner, B.
1997.
Vorkommen und Bekämpfung der Protothekenmastitis des Rindes im Einzugsgebiet des Staatlichen Veterinär- und Lebensmitteluntersuchungsamtes Potsdam.
Prakt. Tierarzt
78:406-414.
|
| 4.
|
Blaschke-Hellmessen, R.,
H. Schuster, and V. Bergmann.
1985.
Differenzierung von Varianten bei Prototheca zopfii (Krüger 1894).
Arch. Exp. Veterinarmed.
39:387-397[Medline].
|
| 5.
|
Blaschke-Hellmessen, R.,
A. Wilhelm,
G. Teichmann,
H. Schuster, and K. Boeltzig.
1987.
Orientierende Untersuchungen zum Nachweis von Antikörpern gegen Prototheca zopfii bei Rindern.
Mh. Vet. Med.
42:48-50.
|
| 6.
|
Butler, J. E.,
T. L. Feldbush,
P. L. McGivern, and N. Stewart.
1978.
The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity.
Immunochemistry
15:131-136[CrossRef][Medline].
|
| 7.
|
Carey, W. P.,
Y. Kaykova,
J. C. Bandres,
G. S. Sidhu, and N. Brau.
1997.
Cutaneous protothecosis in a patient with AIDS and a severe functional neutrophil defect: successful therapy with amphotericin B.
Clin. Infect. Dis.
25:1265-1266[Medline].
|
| 8.
|
Casal, M., and A. J. Gutierrez.
1983.
In vitro activity of ribostamycin against Prototheca sp.
Mycopathologia
83:21-23[CrossRef][Medline].
|
| 9.
|
Costa, E. O.,
A. C. Carciofi,
P. A. Melville,
M. S. Prada, and U. Schalch.
1996.
Prototheca sp. outbreak of bovine mastitis.
Zentbl. Veterinarmed. [B]
43:321-324.
|
| 10.
|
Da Costa, E. O.,
A. R. Ribeiro,
E. T. Watanabe,
R. B. Pardo,
J. B. Silva, and R. B. Sanches.
1996.
An increased incidence of mastitis caused by Prototheca species and Nocardia species on a farm in Sao Paulo, Brazil.
Vet. Res. Commun.
20:237-241[Medline].
|
| 11.
|
Enders, F., and A. Weber.
1993.
Untersuchungen zum Vorkommen von Prototheken in Kotproben von Rindern.
Berl. Munch. Tierarztl. Wochenschr.
106:165-169[Medline].
|
| 12.
|
Hensel, A.,
R. Pabst,
S. Bunka, and K. Petzoldt.
1994.
Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.
Clin. Exp. Immunol.
96:91-97[Medline].
|
| 13.
|
Hodges, R. T.,
J. T. S. Holland,
F. J. A. Neilson, and N. M. Wallace.
1985.
Prototheca zopfii mastitis in a herd of dairy cows.
N.Z. Vet. J.
33:108-111.
|
| 14.
|
Jark, U.,
I. Ringena,
B. Franz,
G. F. Gerlach,
M. Beyerbach, and B. Franz.
1997.
Development of an ELISA technique for serodiagnosis of bovine paratuberculosis.
Vet. Microbiol.
57:189-198[CrossRef][Medline].
|
| 15.
|
Jensen, H. E.,
B. Aalbaek,
B. Bloch, and A. Huda.
1998.
Bovine mammary protothecosis due to Prototheca zopfii.
Med. Mycol.
36:89-95[CrossRef][Medline].
|
| 16.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 17.
|
Lerche, M.
1952.
Eine durch Algen (Prototheca) hervorgerufene Mastitis der Kuh.
Berl. Munch. Tierarztl. Wochenschr.
4:64-69.
|
| 18.
|
Matsuda, T., and T. Matsumoto.
1992.
Protothecosis: a report of two cases in Japan and a review of the literature.
Eur. J. Epidemiol.
8:397-406[CrossRef][Medline].
|
| 19.
|
McGill, R.,
J. W. Tukey, and W. A. Larson.
1978.
Variations of box plots.
Am. Statist.
32:12-16[CrossRef].
|
| 20.
|
Mohabeer, A. J.,
P. J. Kaplan,
P. M. Southern, Jr., and R. M. Gander.
1997.
Algaemia due to Prototheca wickerhamii in a patient with myasthenia gravis.
J. Clin. Microbiol.
35:3305-3307[Abstract].
|
| 21.
|
Paar, F.,
B. Franz,
N. Nowotny, and K. Petzold.
1989.
Entwicklung eines Enzyme-linked-immunosorbent-assay (ELISA) zum Nachweis von Antikörpern in Perdeseren gegen das Equine Herpesvirus 3.
Wien. Tierarztl. Mschr.
76:401-404.
|
| 22.
|
Pore, R. S.
1973.
Selektive medium for the isolation of Prototheca.
Appl. Microbiol.
26:648-649[Medline].
|
| 23.
|
Pore, R. S.,
E. A. Barnett,
W. C. Barnes, Jr., and J. D. Walker.
1983.
Prototheca ecology.
Mycopathologia
81:49-62[CrossRef][Medline].
|
| 24.
|
Pore, R. S.,
T. A. Shahan,
M. D. Pore, and R. Blauwiekel.
1987.
Occurrence of Prototheca zopfii, a mastitis pathogen, in milk.
Vet. Microbiol.
15:315-323[CrossRef][Medline].
|
| 25.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Detection and analysis of proteins expressed from cloned genes, p. 18.3-18.74.
In
J. Sambrook, E. F. Fritsch, and T. Maniatis (ed.), Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 26.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5467.
|
| 27.
|
Schick, W., and H. Kutzer.
1982.
Zum Auftreten, zur Diagnostik und zur Bekämpfung der durch Prototheca trispora bedingten Mastitis des Rindes.
Mh. Vet. Med.
37:295-298.
|
| 28.
|
Schlenstedt, R.,
M. Zschock,
B. Kloppert, and W. Wolter.
1997.
Vorkommen von Protothekenmastitiden in hessischen Milcherzeugerbetrieben.
Tierarztl. Prax. Ausg. G. Grosstiere.
25:407-412.
|
| 29.
|
Schmalreck, A. F.,
P. Trankle,
E. Vanca, and R. Blaschke-Hellmessen.
1998.
Differenzierung und Charakterisierung von humanpathogenen Hefen (Candida albicans, Exophiala dermatidis) und tierpathogenen Algen (Prototheca spp.) mittels Fourier-Transform-Infrarot-Spektroskopie (FT-IR) im Vergleich zu konventionellen Methoden.
Mycoses
41(Suppl. 1):71-77.
|
| 30.
|
Schuster, H., and R. Blaschke-Hellmessen.
1983.
Zur Epidemiologie der Protothekenmastitis des Rindes-Anzüchtung von Algen der Gattung Prototheca aus der Umgebung landwirtschaftlicher Nutztiere.
Mh. Vet. Med.
38:24-29.
|
| 31.
|
Tenhagen, B. A.,
P. Kalbe,
G. Klunder,
W. Heuwieser, and B. Baumgartner.
1999.
Tierindividuelle Risikofaktoren für die Protothekenmastitis des Rindes.
DTW Dtsch. Tierarztl. Wochenschr.
106:376-380.
|
| 32.
|
Thiele, D.
1997.
Protothekosen bei Mensch und Tier sowie In-vitro-Untersuchungen zur Wirksamkeit und lokalen Euterverträglichkeit von Polyvinylpyrrolidon-Iodlösung und Lugolscher Lösung. Ph.D. thesis.
University of Leipzig, Leipzig, Germany.
|
| 33.
|
Tyler, J. W., and J. S. Cullor.
1989.
Titers, tests, and truisms: rational interpretation of diagnostic serologic testing.
J. Am. Vet. Med. Assoc.
194:1550-1558[Medline].
|
| 34.
|
Wirth, F. A.,
J. A. Passalacqua, and G. Kao.
1999.
Disseminated cutaneous protothecosis in an immunocompromised host: a case report and literature review.
Cutis
63:185-188[Medline].
|
Journal of Clinical Microbiology, February 2001, p. 539-543, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.539-543.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lass-Florl, C., Mayr, A.
(2007). Human Protothecosis. Clin. Microbiol. Rev.
20: 230-242
[Abstract]
[Full Text]
-
Marques, S., Silva, E., Carvalheira, J., Thompson, G.
(2006). Short communication: In vitro antimicrobial susceptibility of Prototheca wickerhamii and Prototheca zopfii isolated from bovine mastitis.. J DAIRY SCI
89: 4202-4204
[Abstract]
[Full Text]
-
Roesler, U., Moller, A., Hensel, A., Baumann, D., Truyen, U.
(2006). Diversity within the current algal species Prototheca zopfii: a proposal for two Prototheca zopfii genotypes and description of a novel species, Prototheca blaschkeae sp. nov.. Int. J. Syst. Evol. Microbiol.
56: 1419-1425
[Abstract]
[Full Text]
-
Roesler, U., Scholz, H., Hensel, A.
(2003). Emended phenotypic characterization of Prototheca zopfii: a proposal for three biotypes and standards for their identification. Int. J. Syst. Evol. Microbiol.
53: 1195-1199
[Abstract]
[Full Text]
-
Roesler, U., Hensel, A.
(2003). Longitudinal Analysis of Prototheca zopfii-Specific Immune Responses: Correlation with Disease Progression and Carriage in Dairy Cows. J. Clin. Microbiol.
41: 1181-1186
[Abstract]
[Full Text]